{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:04:11Z","timestamp":1769580251171,"version":"3.49.0"},"reference-count":46,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:sec><jats:title>Context:<\/jats:title><jats:p>Craniopharyngiomas are often associated with significant morbidity due to their location and treatment effects. Little is known of the effects of primary treatment regimen and diabetes insipidus (DI), a clinical surrogate of hypothalamic obesity, on health outcomes in adults with childhood-onset craniopharyngioma (COCP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The objective of the study was to examine health outcomes of adults with COCP based on primary treatment regimens and the presence of DI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design:<\/jats:title><jats:p>This study included a retrospective KIMS (Pfizer International Metabolic Database) data analysis of 180 adults with COCP according to the primary treatment regimen [one surgery (1Surg) vs complex treatment regimen (CTrR) of more than 1Surg and\/or radiotherapy] and the presence of DI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The majority of COCP patients underwent transcranial surgery (77%) without receiving radiotherapy (84%). Compared with the 1Surg group, more CTrR patients developed visual field defects and ophthalmoplegia (all P &amp;lt; .01). Compared with patients without DI, those with DI had higher rates of anterior pituitary hormone deficits, body mass index, and fat mass (all P &amp;lt; .01). By contrast, fasting glucose, hemoglobin A1c, lipid panel, and quality of life were comparable among 1Surg vs CTrR patients, and patients with vs without DI. Regardless of primary treatment received, the presence of DI in either group was associated with higher rates of anterior pituitary hormone deficits and obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>CTrR and DI predicted health outcomes differently. CTrR predisposed to the development of visual dysfunction, whereas DI was associated with higher rates of anterior pituitary dysfunction and weight gain. Higher body mass index and fat mass in patients with DI further implicate the role of hypothalamic damage as an important causal factor of obesity in these patients.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2013-3631","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T16:57:47Z","timestamp":1391014667000},"page":"1227-1235","source":"Crossref","is-referenced-by-count":16,"title":["Primary Treatment Regimen and Diabetes Insipidus as Predictors of Health Outcomes in Adults With Childhood-Onset Craniopharyngioma"],"prefix":"10.1210","volume":"99","author":[{"given":"Kevin C. J.","family":"Yuen","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Clinical Nutrition (K.C.J.Y., D.M.C.), Department of Medicine, Oregon Health and Science University, Portland, Oregon 97239;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ko\u0142towska-H\u00e4ggstr\u00f6m","sequence":"first","affiliation":[{"name":"Pfizer Endocrine Care (M.K.-H., P.J.J.), Pfizer Inc, SE-190 91 Sollentuna, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Cook","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Clinical Nutrition (K.C.J.Y., D.M.C.), Department of Medicine, Oregon Health and Science University, Portland, Oregon 97239;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet L.","family":"Fox","sequence":"first","affiliation":[{"name":"Pfizer Endocrine Care (J.L.F.), Pfizer, Inc, New York, New York 10017;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"J\u00f6nsson","sequence":"first","affiliation":[{"name":"Pfizer Endocrine Care (M.K.-H., P.J.J.), Pfizer Inc, SE-190 91 Sollentuna, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell E.","family":"Geffner","sequence":"first","affiliation":[{"name":"The Saban Research Institute (M.E.G.), Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California 90027;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Abs","sequence":"first","affiliation":[{"name":"Antwerp Centre for Endocrinology (R.A.), Antwerp B-2600, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"issue":"1","key":"2020071612593784000_B1","first-page":"14","article-title":"Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990\u20131994","volume":"1","author":"Surawicz","year":"1999","journal-title":"Neuro Oncol"},{"issue":"4","key":"2020071612593784000_B2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2265.2010.03838.x","article-title":"Morbidity and mortality in patients with craniopharyngioma after surgery","volume":"73","author":"Crowley","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071612593784000_B3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","article-title":"High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma","volume":"62","author":"Pereira","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2020071612593784000_B4","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1210\/jc.2011-0174","article-title":"Consequences of craniopharyngioma surgery in children","volume":"96","author":"Muller","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612593784000_B5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11102-012-0401-0","article-title":"Childhood craniopharyngioma","volume":"16","author":"Muller","year":"2013","journal-title":"Pituitary"},{"issue":"6","key":"2020071612593784000_B6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1227\/00006123-199412000-00001","article-title":"Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome","volume":"35","author":"Weiner","year":"1994","journal-title":"Neurosurgery"},{"issue":"2","key":"2020071612593784000_B7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3171\/jns.1999.90.2.0237","article-title":"Surgical treatment of craniopharyngiomas: experience with 168 patients","volume":"90","author":"Fahlbusch","year":"1999","journal-title":"J Neurosurg"},{"issue":"4","key":"2020071612593784000_B8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3171\/2012.7.PEDS11436","article-title":"Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review","volume":"10","author":"Clark","year":"2012","journal-title":"J Neurosurg Pediatr"},{"key":"2020071612593784000_B9","first-page":"3","article-title":"Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement","volume":"106","author":"Puget","year":"2007","journal-title":"J Neurosurg"},{"issue":"6","key":"2020071612593784000_B10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2004-832339","article-title":"Prognosis and sequela in patients with childhood craniopharyngioma\u2014results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000","volume":"216","author":"Muller","year":"2004","journal-title":"Klin Padiatr"},{"issue":"4","key":"2020071612593784000_B11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2011-2817","article-title":"Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients","volume":"97","author":"Gautier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071612593784000_B12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"3","key":"2020071612593784000_B13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0360-3016(02)02799-2","article-title":"Craniopharyngioma: the St Jude Children's Research Hospital experience 1984\u20132001","volume":"53","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6665","key":"2020071612593784000_B14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.298.6665.2","article-title":"Postoperative diabetes insipidus","volume":"298","author":"Seckl","year":"1989","journal-title":"BMJ"},{"key":"2020071612593784000_B15","first-page":"94","article-title":"Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function","volume":"104","author":"Merchant","year":"2006","journal-title":"J Neurosurg"},{"issue":"4","key":"2020071612593784000_B16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma\u2014German multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"Muller","year":"2001","journal-title":"Klin Padiatr"},{"issue":"2","key":"2020071612593784000_B17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00006123-200002000-00007","article-title":"Long-term outcomes for surgically resected craniopharyngiomas","volume":"46","author":"Duff","year":"2000","journal-title":"Neurosurgery"},{"issue":"4","key":"2020071612593784000_B18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612593784000_B19","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1210\/jc.2013-2000","article-title":"Hypothalamic involvement predicts cognitive performance and psychosocial health in long term survivors of childhood craniopharyngioma","volume":"98","author":"Fjalldal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071612593784000_B20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2003-45499","article-title":"Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma","volume":"215","author":"Muller","year":"2003","journal-title":"Klin Padiatr"},{"issue":"1","key":"2020071612593784000_B21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pds.1510","article-title":"Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database)","volume":"17","author":"Gutierrez","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020071612593784000_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients\u20142009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"issue":"6","key":"2020071612593784000_B23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071612593784000_B24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"2020071612593784000_B25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/978-3-642-71809-0_23","article-title":"Radioimmunoassay of the somatomedins\/insulin-like growth factors","volume-title":"Radioimmunoassay in Basic and Clinical Pharmacology","author":"Underwood","year":"1987"},{"issue":"7","key":"2020071612593784000_B26","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1210\/jc.2007-0153","article-title":"Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency","volume":"92","author":"Brabant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612593784000_B27","first-page":"53","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","author":"Brabant","year":"2003","journal-title":"Horm Res"},{"issue":"10","key":"2020071612593784000_B28","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin Chem"},{"issue":"5","key":"2020071612593784000_B29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/clinchem\/23.5.882","article-title":"Cholesterol determination in high-density lipoproteins separated by three different methods","volume":"23","author":"Lopes-Virella","year":"1977","journal-title":"Clin Chem"},{"issue":"4","key":"2020071612593784000_B30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual Life Res"},{"issue":"4","key":"2020071612593784000_B31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/er.2006-0002","article-title":"Craniopharyngiomas","volume":"27","author":"Karavitaki","year":"2006","journal-title":"Endocr Rev"},{"issue":"6","key":"2020071612593784000_B32","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2012-3928","article-title":"Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity","volume":"98","author":"Elowe-Gruau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071612593784000_B33","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence","volume":"83","author":"Bulow","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"2020071612593784000_B34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01400850","article-title":"Status of vision following surgical treatment of craniopharyngiomas","volume":"73","author":"Cabezudo Artero","year":"1984","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"2020071612593784000_B35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1148\/120.1.167","article-title":"Visual complications following irradiation for pituitary adenomas and craniopharyngiomas","volume":"120","author":"Harris","year":"1976","journal-title":"Radiology"},{"issue":"7","key":"2020071612593784000_B36","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"Muller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612593784000_B37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/jc.2003-030442","article-title":"Features of the metabolic syndrome after childhood craniopharyngioma","volume":"89","author":"Srinivasan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071612593784000_B38","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071612593784000_B39","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1210\/jc.2004-0667","article-title":"Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database)","volume":"89","author":"Geffner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071612593784000_B40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-010-0145-5","article-title":"Late mortality in pediatric patients with craniopharyngioma","volume":"100","author":"Visser","year":"2010","journal-title":"J Neurooncol"},{"issue":"4","key":"2020071612593784000_B41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00005792-197507000-00002","article-title":"Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature","volume":"54","author":"Bray","year":"1975","journal-title":"Medicine"},{"issue":"5","key":"2020071612593784000_B42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-09-0449","article-title":"Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy","volume":"161","author":"Holmer","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2020071612593784000_B43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00254505","article-title":"Hypothalamic obesity. The autonomic hypothesis and the lateral hypothalamus","author":"Bray","year":"1981","journal-title":"Diabetologia"},{"key":"2020071612593784000_B44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2431-9-24","article-title":"Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index","volume":"9","author":"Trivin","year":"2009","journal-title":"BMC Pediatr"},{"issue":"3","key":"2020071612593784000_B45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/eje.1.02114","article-title":"Quality of life in treated adult craniopharyngioma patients","volume":"154","author":"Dekkers","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2020071612593784000_B46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.1.01877","article-title":"The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma","volume":"152","author":"Kendall-Taylor","year":"2005","journal-title":"Eur J Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/4\/1227\/9046761\/jcem1227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/4\/1227\/9046761\/jcem1227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:23:22Z","timestamp":1716492202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/4\/1227\/2537289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-3631","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}